Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Capital Markets Event

5 Dec 2024 07:00

RNS Number : 8258O
Sabre Insurance Group PLC
05 December 2024
Β 

Sabre Insurance Group plc

Capital Markets Event, 5th December 2024

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, will today host a Capital Markets Event for investors and analysts at 3.30pm GMT in London, providing an update on the Group's strategy and medium-term growth objectives.

Management will discuss the Group's 'Ambition 2030' strategy, through which it aims to deliver a profit before tax of at least Β£80m in 2030, representing a compound annual growth rate across the period of c.10%.

A recording of the presentations and all materials will be available on the Sabre Insurance Group plc website at https://sabreplc.co.uk/investors/results-centre/ following the event.

Current trading

A brief update on current market trading conditions will be provided at today's event, with management reiterating guidance for the current financial year ending 31 December 2024. We continue to anticipate our highest ever gross written premium in 2024, and profit in line with current market expectations.

Geoff Carter, CEO of Sabre Insurance Group, commented:

"Today's Capital Markets Event is an opportunity for our management team to outline Sabre's ability to deliver material growth across the cycle, whilst maintaining the core principles that have delivered exceptional returns and resilience over the Group's more than 30 years as an underwriter.

The delivery of our 'Ambition 2030' will be underpinned by our proven skills and data, supported by the roll-out of significant technological enhancements to our pricing infrastructure. We will be targeting profit growth through balancing income and margin and continuing to maintain resolute underwriting discipline. In addition, we are enhancing distribution across our Motorcycle business, including the launch of a new, online-only direct Motorcycle brand in Q1 2025. All growth initiatives leverage existing Sabre strengths, do not require capital investment and can be rolled out in a controlled manner.

I am looking forward to sharing our exciting ambition for the future and will report on our progress in subsequent market updates."

Β 

Investor enquiries

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

01306 747 272

Media enquiries

Teneo

020 7353 4200

James Macey White / Ffion Dash

sabre@teneo.com

LEI Code: 2138006RXRQ8P8VKGV98

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCTIBTTMTAMBII
Date   Source Headline
23rd Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20262:10 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20264:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.